Novartis AG
Change company Symbol lookup
Select an option...
NVS Novartis AG
FRBA FIRST BANK (Hamilton)
UNM Unum Group
LLY Eli Lilly and Co
BDC Belden Inc
TTM Tata Motors Ltd
HOG Harley-Davidson Inc
SKY Skyline Champion Corp
MMM 3M Co
MPX Marine Products Corp
Go

Health Care : Pharmaceuticals | Large Cap Value
Based in Switzerland
Company profile

Novartis AG is a holding company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. The Company's segments include Innovative Medicines, Sandoz, Alcon and Corporate activities. Innovative Medicines researches, develops, manufactures, distributes and sells patented prescription medicines to develop health outcomes for patients and healthcare providers. Sandoz develops, manufactures, distributes and sells prescription medicines, as well as pharmaceutical active substances that are not protected by valid and enforceable third-party patents. Alcon researches, develops, manufactures, distributes and sells eye care products. Alcon is a provider of eye care with product offerings in eye care devices and vision care. The Company's range of products includes pharmaceuticals and oncology medicines, generic and biosimilar medicines, and eye care devices.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Price
Delayed
$78.98
Day's Change
-1.97 (-2.43%)
Bid
--
Ask
--
B/A Size
--
Day's High
79.72
Day's Low
78.58
Volume
(Heavy Day)

Today's volume of 616,994 shares is on pace to be much greater than NVS's 10-day average volume of 1,640,966 shares.

616,994

STAA STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against STAAR Surgical Company - STAA

10:40 am ET September 25, 2020 (Globe Newswire) Print

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of STAAR Surgical Company (NASDAQ: STAA) between February 26, 2020 and August 10, 2020, inclusive (the "Class Period"). The lawsuit seeks to recover investor losses under the federal securities laws.

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=staar-surgical-company&id=2405 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.

å¦?æ??æ?¨æ?³å? å?¥è¿?个é??ä½"è¯?讼æ¡?ï¼?请å?¨è¿?é??提交æ?¨ç??信息ã??http://zhanginvestorlaw.com/join-action-form/?slug=staar-surgical-company&id=2405

If you wish to serve as lead plaintiff, you must move the Court before the OCTOBER 19, 2020 DEADLINE. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) its sales and growth in China; (2) its marketing spend; (3) its research and development expenses; and (4) as a result of the foregoing, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

Lead plaintiff status is not required to seek compensation. You may retain counsel of your choice. You may remain an absent class member and take no action at this time.

Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.

Zhang Investor Law P.C.

99 Wall Street, Suite 232

New York, New York 10005

info@zhanginvestorlaw.com

tel: (800) 991-3756

https://ml.globenewswire.com/media/2e68a1c2-58ac-4be0-98d5-8b26afb52403/small/zahng-investor-law-png.png

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.